[HTML][HTML] Pulmonary delivery of biological drugs
In the last decade, biological drugs have rapidly proliferated and have now become an
important therapeutic modality. This is because of their high potency, high specificity and …
important therapeutic modality. This is because of their high potency, high specificity and …
Viral emerging diseases: challenges in develo** vaccination strategies
In the last decades, a number of infectious viruses have emerged from wildlife or re-
emerged, generating serious threats to the global health and to the economy worldwide …
emerged, generating serious threats to the global health and to the economy worldwide …
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Cost-effective, efficacious therapeutics are urgently needed to combat the COVID-19
pandemic. In this study, we used camelid immunization and proteomics to identify a large …
pandemic. In this study, we used camelid immunization and proteomics to identify a large …
An update of anti-viral treatment of COVID-19.
S ŞİMŞEK YAVUZ… - Turkish journal of …, 2021 - search.ebscohost.com
Background/aim: Currently there is not an effective antiviral treatment for COVID-19, but a
large number of drugs have been evaluated since the beginning of the pandemic, and many …
large number of drugs have been evaluated since the beginning of the pandemic, and many …
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses
Globally, there is an urgency to develop effective, low-cost therapeutic interventions for
coronavirus disease 2019 (COVID-19). We previously generated the stable and ultrapotent …
coronavirus disease 2019 (COVID-19). We previously generated the stable and ultrapotent …
[HTML][HTML] The find of COVID-19 vaccine: Challenges and opportunities
Severe acute respiratory syndrome coronavirus (SARS-CoV-2), a novel corona virus,
causing COVID-19 with Flu-like symptoms is the first alarming pandemic of the third …
causing COVID-19 with Flu-like symptoms is the first alarming pandemic of the third …
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
L Chitsike, P Duerksen-Hughes - Virology Journal, 2021 - Springer
The COVID-19 pandemic has put healthcare infrastructures and our social and economic
lives under unprecedented strain. Effective solutions are needed to end the pandemic while …
lives under unprecedented strain. Effective solutions are needed to end the pandemic while …
Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2
The recent outbreak of SARS-CoV-2 has forever altered mankind resulting in the COVID-19
pandemic. This respiratory virus further manifests into vital organ damage, resulting in …
pandemic. This respiratory virus further manifests into vital organ damage, resulting in …
[HTML][HTML] Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era
S Pecetta, O Finco, A Seubert - Seminars in immunology, 2020 - Elsevier
In recent years the global market for monoclonal antibodies (mAbs) became a multi-billion-
dollar business. This success is mainly driven by treatments in the oncology and …
dollar business. This success is mainly driven by treatments in the oncology and …
A comprehensive comparison between camelid nanobodies and single chain variable fragments
Y Asaadi, FF Jouneghani, S Janani… - Biomarker Research, 2021 - Springer
By the emergence of recombinant DNA technology, many antibody fragments have been
developed devoid of undesired properties of natural immunoglobulins. Among them …
developed devoid of undesired properties of natural immunoglobulins. Among them …